Search the Newsreel

VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead

Papa John’s Gets Final Approval of $5 Million No-Poach Pact Deal

Papa John’s International Inc. has received final approval for a $5 million settlement to resolve antitrust claims related to its franchisee no-poach agreements. The settlement, which covers suppressed employee wages and reduced worker mobility, was approved by Judge Benjamin Beaton despite being significantly lower …

Killam Apartment REIT Announces August 2026 Distribution

HALIFAX, NS, Aug. 17, 2026 /CNW/ -- Killam Apartment REIT (TSX: KMP.UN) is pleased to announce its August 2026 monthly distribution. The distribution of $0.06 per unit will be paid on September 15, 2026, to unitholders of record on August 31, 2026. About Killam …

Why Applied Materials (AMAT) Could Be a Major Winner of the AI Memory Surge

Aristotle Capital Management, LLC, an investment management company, released its "Core Equity Fund" Q2 2026 investor letter. A copy of the letter can be downloaded here. The fund returned 14.69% in the second quarter of 2026, slightly trailing the 15.20% gain of the S&P …

CAMP4 Therapeutics (CAMP) Q1 2026 Earnings: Wider-than-Expected Loss Weighs on Shares - Dividend Earnings Report

Apple to change app data consent rules, German regulator says

Apple will revise its App Tracking Transparency (ATT) framework after Germany's competition authority, the Federal Cartel Office (FCO), found that Apple's own apps received more favorable consent prompts than third-party developers. The FCO's investigation, which lasted several years, concluded that Apple's practices potentially breached …

Velan group shifts to passive stake in Jasper (NASDAQ: JSPR)

The Velan group, including Velan Capital Investment Management LP, has filed a Schedule 13G indicating a shift to a passive investment stake of approximately 9.9% in Jasper Therapeutics, Inc. (NASDAQ: JSPR). This filing signifies that the group no longer holds Jasper securities with the …

Top Ridgepost Capital (RPC) Competitors 2026

Marcus & Millichap Shares Jump After Swing to Profit, But Valuation Questions Linger

Marcus & Millichap (MMI) recently reported a swing to profit in Q2 2026, with net income of $3.91 million on $202.92 million revenue, leading to a jump in share price. Despite share buybacks and a maintained dividend, a valuation framework suggests the stock might …

Applied Materials Earnings Highlight AI Demand, Yet Capacity Constraints Remain the Limit

Applied Materials exceeded revenue and guidance expectations, reflecting strong AI-driven chip demand, but its stock declined due to a lack of specific future systems guidance. The company is prioritizing manufacturing capacity expansion to address physical production limits that are now the primary constraint on …

A Quick Look at Today's Ratings for Context Therapeutics(CNTX.US), With a Forecast Between $2 to $5

This article provides an overview of current analyst ratings for Context Therapeutics (CNTX.US), indicating a consensus forecast price between $2 and $5. It highlights recent analyst activities, including new coverage or reiterated ratings, which are crucial for investors following the stock. The information aims …

Damora Therapeutics (DMRA) Is Up 5.1% After Starting CLARITY-101 mutCALR Trial Has The Bull Case Changed?

Damora Therapeutics (DMRA) has seen its stock price rise by 5.1% after initiating the global Phase 1/1b CLARITY-101 trial for its investigational mutCALR-targeting antibody DMR-001. This trial aims to address essential thrombocythemia and myelofibrosis, representing a crucial step towards a potential first mutCALR-targeted therapy. …

Apple Stock Got an Upgrade. It Could Be the AI Gatekeeper.

Apple stock received an upgrade, with analysts suggesting the company is well-positioned to become the "AI gatekeeper." The article highlights that while artificial intelligence models are in high demand, the method of distributing these models to consumers will be crucial, a role Apple is …

Apple Makes Major AI Strategy Shift in China, Develops Own LLM With Alibaba’s Support in Bid to Counter Huawei: Report

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Apple Inc. has reportedly partnered with Alibaba Group Holding Ltd. to create an AI model specifically designed for the Chinese market. The AI model will fuel Apple's …

Apple Makes Concessions on Ad Tracking After German Competition Scrutiny

Apple Inc. has agreed to modify its App Tracking Transparency (ATT) system in Europe, resolving a German antitrust investigation. The Federal Cartel Office had raised concerns that Apple's privacy framework gave its own services an unfair advantage over third-party developers by making consent requests …

Abeona Therapeutics Inc (ABEO) (Q2 2026) Earnings Call Highlight

Bad News For Apple Stock Fans

This article first appeared on GuruFocus. Apple (NASDAQ:AAPL) is facing pressure from the U.S. government over plans to source memory components from Chinese suppliers, adding another complication to the company's efforts to secure chips amid tight global supply. Commerce Secretary Howard Lutnick said the …

Applied Materials Q3 FY 2026: Advanced Packaging and DRAM Accelerate Growth

Applied Materials (AMAT) reported a record-breaking Q3 FY 2026, driven by strong demand for AI infrastructure in semiconductor manufacturing equipment, DRAM, and advanced packaging. The company exceeded revenue and EPS expectations, with Semiconductor Systems revenue up 27% YoY and Applied Global Services up 22% …

Apple Wins Major Relief in Antitrust Battle

This article first appeared on GuruFocus. Apple (NASDAQ:AAPL)has ended a years-long German antitrust investigation by agreeing to change how iPhone and iPad users are asked for permission to share data for personalized advertising, reducing one regulatory overhang but forcing Apple to loosen rules that …

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors

TherapeuticsMD Inc. (TXMD) stock fell by 2.90% on Monday, closing at $2.01. This underperformance occurred during a generally poor trading session where both the NASDAQ Composite Index and Dow Jones Industrial Average also experienced declines. This marks the second consecutive day of losses for …

Dune Acquisition Corp II (CCAQ) Stock Price, News & Analysis

Science Applications International (SAIC) Could Be 8% Overvalued As $400 Million Contract Adds Momentum

Apple Could Hit $400, But AI Is Coming for Its Most Profitable Business

Apple Inc. (NASDAQ:AAPL) received a major vote of confidence from Rothschild Redburn today, with the firm upgrading the stock from Neutral to "Buy" and raising its price target to $400 from $260. The upgrade rests on two major catalysts for Apple: its entry into …

Freedom Broker raises Candel Therapeutics stock price target on trial progress

Freedom Broker increased its price target for Candel Therapeutics (NASDAQ:CADL) to $15.00 from $14.00, maintaining a Buy rating, due to significant progress in its clinical trials. The firm cited the start of patient enrollment in the global Phase III AURORA trial for CAN-2409 in …

Mid-America Apartment Communities Inc. stock outperforms competitors despite losses on the day

Mid-America Apartment Communities Inc. (MAA) stock dropped by 1.78% to $131.12 on Monday, marking its second consecutive day of losses. Despite this decline, the stock still outperformed the broader market, as the S&P 500 Index and Dow Jones Industrial Average also experienced losses of …

How Investors Are Reacting To AppFolio (APPF) Making AWS Its Preferred AI Cloud Partner

In August 2026, AppFolio, Inc. announced that it has named Amazon Web Services as its preferred cloud provider, with its AI-native Performance Platform and AppFolio Realm suite of AI capabilities now running on AWS infrastructure including Express Brokers for Amazon MSK and Amazon Bedrock. …

Sandisk, Micron, Coherent, Boeing, Apple, Amazon, and More Stocks That Explain Today’s Market

Coherent is the best-performing stock in the S&P 500 on Monday. Sandisk, Micron, Marvell, and other AI stocks also rise. . Continue Reading

Capricor Therapeutics Soars As FDA Keeps Deramiocel Path Alive

Capricor Therapeutics (CAPR) stock surged after the FDA agreed to review an amended filing for its Duchenne muscular dystrophy drug, deramiocel, focusing on upper-limb function. Cantor Fitzgerald upgraded CAPR to Overweight with a significantly raised price target of $28. Despite no revenue and widening …

Wrap Technologies prices $12M stock offering at $1.40 per share

Wrap Technologies Inc. announced the pricing of a registered direct offering of 8,571,609 shares of common stock or pre-funded warrants at $1.40 per share, aiming to raise approximately $12.0 million. The public safety technology company intends to use the proceeds for general corporate purposes …

Pantages Capital Acquisition (PGAC) Holds at $10.69 as SPAC Trades Within Range - EMA Signal

Oppenheimer Maintains Quince Therapeutics(QNCX.US) With Buy Rating, Maintains Target Price $82

Oppenheimer has reiterated its Buy rating on Quince Therapeutics (QNCX.US), maintaining a target price of $82. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.

OCUL Stock Climbs As FDA Clears Path For AXPAXLI NDA

Ocular Therapeutix Inc. (OCUL) stock climbed by 8.12% after the FDA agreed that a single successful Phase 3 SOL-1 trial, combined with safety data, is sufficient for an AXPAXLI wet AMD New Drug Application (NDA) via the 505(b)(2) pathway. The company reported a Q2 …

West Coast Paper Mills passes all 8 resolutions at 71st AGM

At US$507, Is Applied Materials, Inc. (NASDAQ:AMAT) Worth Looking At Closely?

This article analyzes Applied Materials, Inc. (NASDAQ:AMAT) from a valuation perspective, questioning if its current share price of US$507 makes it an attractive investment. It suggests a closer look at the company's financial health and future prospects to determine if it is undervalued or …

Apple’s $54 billion iPhone machine may be about to break its biggest ritual

For nearly two decades, September has usually meant one thing for Apple investors: a new iPhone cycle. That pattern may be about to change. Apple (AAPL) is reportedly planning to launch the iPhone 18 Pro series this fall and delay the standard iPhone 18 …

OCUL Stock Climbs As FDA Path And Cash Runway De‑Risk Story